Recommended Cefepime Dosing for Pneumonia in Dialysis Patients
For patients with acute renal failure on hemodialysis with pneumonia, administer cefepime 2 g IV after each dialysis session (three times weekly), with the first dose given on day 1 followed by 1 g after each subsequent dialysis session for non-severe infections, or maintain 2 g after each session for severe pneumonia or high-risk pathogens.
Dosing Algorithm Based on Clinical Severity and Pathogen Risk
For Standard Hospital-Acquired Pneumonia (HAP)
- Initial dose: 2 g IV on day 1 immediately after dialysis
- Maintenance: 1 g IV after each dialysis session (3x/week) 1, 2
- This achieves trough levels of 20-30 mg/L, well above MIC₉₀ for most pathogens 2
For Severe Pneumonia or Pseudomonas aeruginosa Coverage
- Dose: 2 g IV after each dialysis session (3x/week) 1, 3, 4
- Required when:
- Ventilator-associated pneumonia (VAP)
- Septic shock present
- Known or suspected P. aeruginosa (MIC ≥8 mg/L)
- Prior IV antibiotic use within 90 days 5
Critical Timing Considerations
Always administer cefepime immediately after dialysis completion 1, 2. This is essential because:
- Hemodialysis removes approximately 68-81% of cefepime during a 3-4 hour session 1, 2, 3
- Post-dialysis dosing prevents premature drug removal
- Facilitates directly observed therapy compliance
Pharmacokinetic Rationale
The interdialytic half-life of cefepime extends to 13.5-22 hours in hemodialysis patients (versus 2 hours in normal renal function) 1, 2. This prolonged half-life allows three-times-weekly dosing to maintain therapeutic levels between sessions. Studies demonstrate that 2 g post-dialysis achieves:
- Peak concentrations: 165.6 ± 48.7 mg/L
- Trough concentrations before next dialysis: 23.3 ± 7.3 mg/L
- Adequate coverage for pathogens with MIC ≤4 mg/L 2
Safety Monitoring Requirements
Neurotoxicity Risk
Cefepime has significant neurotoxic potential in renal failure, with a lower threshold than other beta-lactams 6. Monitor closely for:
- Confusion, altered mental status
- Myoclonus, muscle jerks
- Non-convulsive seizures
- Encephalopathy
Target trough levels: Keep below 20-22 mg/L to minimize neurotoxicity risk 6, 7. Cefepime has a relative pro-convulsive activity of 160 (compared to penicillin G = 100) 6.
When to Adjust Dosing
Reduce to 1 g post-dialysis if:
- Patient develops neurological symptoms
- Infection caused by highly susceptible organisms (MIC ≤2 mg/L)
- Clinical improvement after initial high-dose therapy 3
Increase to 1.5-2 g post-dialysis if:
- P. aeruginosa infection (especially if MIC >4 mg/L)
- Patient has residual urine output (not anuric)
- Severe sepsis or VAP 3, 4
Common Pitfalls to Avoid
- Do not dose cefepime before dialysis - this wastes medication and risks underdosing
- Do not use standard renal dosing charts - these recommend daily dosing (e.g., 1 g q24h for CrCl <10 mL/min) which is inappropriate for intermittent hemodialysis 1
- Do not assume all dialysis patients need the same dose - those with residual renal function require higher doses due to additional non-dialytic clearance 3
- Do not overlook neurotoxicity symptoms - confusion in dialysis patients is often attributed to uremia rather than antibiotic toxicity 7
Continuous Ambulatory Peritoneal Dialysis (CAPD)
If patient is on CAPD instead of hemodialysis:
- Dose: 2 g IV every 48 hours 1
- CAPD removes cefepime less efficiently than hemodialysis
- Adjust based on clinical response and infection severity
Duration of Therapy
Follow standard pneumonia treatment durations per IDSA/ATS guidelines 5:
- HAP: 7-10 days
- VAP: 7-10 days
- Extend to 14 days if P. aeruginosa or slow clinical response
The three-times-weekly post-dialysis regimen has demonstrated excellent clinical outcomes with 72.7% 30-day survival in septic dialysis patients and effective microbiologic cure rates 4.